The therapeutic community is buzzing with anticipation surrounding retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing significant efficacy in clinical trials for addressing obesity. Unlike some current weight loss solutions, retatrutide appears to deliver a more substantial loss in body weight and improve metabolic function, par